Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ERIVEDGE Kaps 150 mg Ds 28 Stk
Drug
Erivedge, Kapseln
Zytostatikum
07.16.4. – others
HAM – Human medicine
KAHA – Capsule, hard
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
5/30/2013
12/31/9999
Dosage strength
Erivedge, Kapseln
Zytostatikum
01
Z – approved
Package
7680624970014
No information made available
A/R – Authorised / referenced
28 capsule(s)
001
Z – approved
Declaration
Component
150 mg vismodegibum
cellulosum microcristallinum
71.5 mg lactosum monohydricum
natrii laurilsulfas
povidonum K 29-32
carboxymethylamylum natricum
talcum
magnesii stearas
gelatina
E 171
E 172 (rubrum)
E 172 (nigrum)
lacca
E 172 (nigrum)
1.09 - 1.34 mg natrium
71.5 mg lactosum monohydricum
natrii laurilsulfas
povidonum K 29-32
carboxymethylamylum natricum
talcum
magnesii stearas
gelatina
E 171
E 172 (rubrum)
E 172 (nigrum)
lacca
E 172 (nigrum)
1.09 - 1.34 mg natrium
Spezialitätenliste***
SL
-
-
5255.45
None
Yes
10%
No
Authorisation holder
7601001010208
Roche Pharma (Schweiz) AG
Grenzacherstrasse 124
4058 Basel (BS)
Grenzacherstrasse 124
4058 Basel (BS)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.